Results for tag: pembrolizumab Total Items Found: 48

Jared Weiss on Radioimmunotherapy for Squamous Cell Carcinoma of the Head and Neck

Type of Page:TapVideo
Edit This Item
Tags for this item:
head and neck cancers symposium
head and neck cancer
cisplatin
cisplatin-ineligible
platinum-ineligible
pembrolizumab
immunotherapy
radioimmunotherapy

Created: 3/3/2020 10:14:46 PM

Julie Graff Results From KEYNOTE-199 on Pembrolizumab Plus Enzalutamide

Type of Page:TapVideo
Edit This Item
Tags for this item:
gu cancers symposium
crpc
pembrolizumab
enzalutamide
immunotherapy
KEYNOTE trials
gu cancers symposium
crpc
pembrolizumab
enzalutamide
immunotherapy
KEYNOTE trials

Created: 2/19/2020 7:49:56 PM

Eyal Meiri on Pembrolizumab in Colorectal Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
TAPUR
gi cancers symposium
pembrolizumab
pretreated
tmb
immunotherapy
colorectal cancer

Created: 1/28/2020 10:01:20 PM

Zev Wainberg on PD-L1­–Positive Advanced Gastric Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
gi cancers symposium
gastric cancer
gastrointestinal cancer
gej cancer
gi cancer
pembrolizumab
immunotherapy
programmed cell death ligand 1

Created: 1/28/2020 8:42:43 PM

Javier Cortes on KEYNOTE-119 Trial of Pembrolizumab vs Chemotherapy in TNBC

Type of Page:TapVideo
Edit This Item
Tags for this item:
keynote 119
pembrolizumab
tnbc
tils
chemotherapy
immunotherapy
san antonio breast
triple-negative breast cancer
keynote 119
pembrolizumab
tnbc
tils
chemotherapy
immunotherapy
san antonio breast
triple-negative breast cancer

Created: 12/13/2019 8:10:08 PM

Nicoletta Colombo on Lenvatinib/Pembrolizumab for Advanced Endometrial Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
endometrial cancer
esmo
lenvatinib
mmr
msi
pembrolizumab

Created: 10/1/2019 7:20:59 AM

Ana Maria Arance Fernandez on Cobimetinib/Atezolizumab vs Pembrolizumab in Melanoma

Type of Page:TapVideo
Edit This Item
Tags for this item:
esmo
imspire170
pembrolizumab
atezolizumab
braf v600
cobimetinib
immunotherapy
melanoma
skin cancer
wild-type

Created: 9/30/2019 2:14:55 PM

Peter Schmid on Pembrolizumab Plus Chemotherapy in TNBC

Type of Page:TapVideo
Edit This Item
Tags for this item:
esmo
keynote-522
pembrolizumab
tnbc
adjuvant
chemotherapy
neoadjuvant
pathologic complete response
triple-negative breast cancer

Created: 9/29/2019 5:04:45 PM

Matt Galsky on Switch Maintenance With Pembrolizumab in Urothelial Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
pembrolizumab
asco 2019
first-line chemotherapy
switch maintenance
urothelial cancer

Created: 6/3/2019 5:12:26 PM

Neeraj Agarwal and Thomas Powles on First-Line Pembrolizumab Plus Axitinib vs Sunitinib in RCC

Type of Page:TapVideo
Edit This Item
Tags for this item:
keynote-426
kidney cancer
pembrolizumab
asco 2019
axitinib
intermediate-risk
poor-risk
renal cell carcinoma
sarcomatoid
sunitinib

Created: 6/3/2019 4:51:22 PM

Danny Rischin on KEYNOTE-048 Trial on Pembrolizumab in HNSCC

Type of Page:TapVideo
Edit This Item
Tags for this item:
head and neck cancer
keynote-048
pembrolizumab
asco 2019
fluorouracil
head and neck squamous cell carcinoma
hnscc
platinum chemotherapy

Created: 6/2/2019 6:53:24 PM

Josep Tabernero on Pembrolizumab in Gastric or GEJ Adenocarcinoma

Type of Page:TapVideo
Edit This Item
Tags for this item:
keynote-062
pembrolizumab
asco 2019
chemotherapy
gastric cancer
gastroesophageal junction cancer

Created: 6/1/2019 5:16:17 PM

Edward Garon on KEYNOTE-001 Trial of Pembrolizumab in NSCLC

Type of Page:TapVideo
Edit This Item
Tags for this item:
asco 2019
keynote-001
lung cancer
NSCLC
pd-l1
pembrolizumab

Created: 6/1/2019 5:09:44 PM

Matthew Gubens on the NSCLC NCCN Guidelines

Type of Page:TapVideo
Edit This Item
Tags for this item:
nccn
nsclc
pembrolizumab
genetic mutations
NCCN guidelines
non-small cell lung cancer
nonsquamous
pd-l1
squamous

Created: 3/21/2019 7:09:52 PM

Nicholas Vogelzang on Lenvatinib Plus Pembrolizumab in Urothelial Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
pembrolizumab
asco sitc
lenvatinib
transitional cell carcinoma
urothelial cancer

Created: 3/5/2019 7:02:14 PM

Brian Rini and Thomas Powles on Pembrolizumab Plus Axitinib vs Sunitinib

Type of Page:TapVideo
Edit This Item
Tags for this item:
Genitourinary Cancers Symposium
keynote-426
pembrolizumab
axitinib
renal cell carcinoma
kidney cancer
sunitinib

Created: 2/19/2019 7:00:25 PM

Takashi Kojima on Esophageal Cancer Results From the KEYNOTE-181 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
gi cancers symposium
keynote-181
pembrolizumab
chemotherapy
esophageal cancer
second-line treatment

Created: 1/23/2019 1:42:48 AM

Jonathan Strosberg on Neuroendocrine Tumors Results From the KEYNOTE-158 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
gi cancers symposium
keynote-158
NETs
pembrolizumab
immunotherapy
neuroendocrine tumors

Created: 1/23/2019 1:36:53 AM

Ronald de Wit on Results From KEYNOTE057

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2018
bladder cancer
KEYNOTE-057
pembrolizumab
immunotherapy
BCG
disease progression

Created: 10/20/2018 12:51:16 PM

Juliet Elizabeth Wolford on Ovarian Cancer The Cost of Care

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2018
ovarian cancer
cost of care
cost-effectiveness
maintenance therapy
paclitaxel
bevacizumab
niraparib
rucaparib
olaparib
pembrolizumab

Created: 6/6/2018 3:03:41 PM

David McDermott on Results of the KEYNOTE-427 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2018
RCC
renal cell carcinoma
KEYNOTE-427
pembrolizumab
first-line therapy
clear cell

Created: 6/4/2018 2:00:38 AM

Aviva Krauss on Multiple Myeloma

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2018
multiple myeloma
FDA
immune-related
adverse events
pembrolizumab

Created: 6/4/2018 1:41:06 AM

Laurence Albiges and Toni Choueiri on Novel Combinations for Advanced RCC

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2018
RCC
renal cell carcinoma
kidney cancer
pegilodecakin
nivolumab
pembrolizumab
CXCR4 inhibitor
axitinib

Created: 6/3/2018 7:46:25 PM

Gilberto Lopes on NSCLC Results From the KEYNOTE-042 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2018
NSCLC
KEYNOTE-042
lung cancer
pembrolizumab
platinum-based chemo
chemotherapy
first-line treatment
PD-L1
tumor proportion score

Created: 6/3/2018 6:02:48 PM

Sumanta K. Pal, MD, on RCC: Results From Two Clinical Trials

Type of Page:TapVideo
Edit This Item
Tags for this item:
Genitourinary Cancers Symposium
genitourinary cancer
RCC
renal cell carcinoma
kidney cancer
IMmotion 151
atezolizumab
bevacizumab
sunitinib
axitinib
pembrolizumab

Created: 2/12/2018 8:17:15 PM

Joaquim Bellmunt, MD, PhD, on Urothelial Cancer: Results From the KEYNOTE-045 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
Genitourinary Cancers Symposium
genitourinary cancer
urothelial cancer
bladder cancer
KEYNOTE-045
pembrolizumab
paclitaxel
docetaxel
vinflunine

Created: 2/12/2018 7:48:04 PM

Jeffrey M. Lemons, MD, on Solid Tumors: Safety Data on SBRT and Immunotherapy

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO
SITC
solid tumors
SBRT
immunotherapy
stereotactic body radiotherapy
pembrolizumab

Created: 1/28/2018 2:43:21 PM

Andrew X. Zhu, MD, PhD, on HCC: Results From KEYNOTE-224

Type of Page:TapVideo
Edit This Item
Tags for this item:
Gastrointestinal Cancers Symposi
gastrointestinal cancer
liver cancer
hepatocellular carcinoma
KEYNOTE-224
pembrolizumab
sorafenib

Created: 1/22/2018 7:56:22 PM

Sherene Loi, MD, PhD, and Roberto Salgado, MD, PhD, on HER2+ Metastatic Breast Cancer: Results From the PANACEA/KEYNOTE 014 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
San Antonio Breast Cancer Sympos
HER2+ breast cancer
metastatic breast cancer
PANACEA
KEYNOTE 014
pembrolizumab
trastuzumab
trastuzumab-resistant disease

Created: 12/7/2017 12:28:36 PM

Primo Lara, MD, on RCC: Expert Perspective on Three Key Papers

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2017
Primo Lara
UC Davis
renal cell carcinoma
kindly cancer
epacadostat
pembrolizumab
atezolizumab
bevacizumab
sunitinib
pazopanib

Created: 6/5/2017 11:53:44 AM

David I. Quinn, MBBS, PhD, on Urothelial Cancer: Results from KEYNOTE-045

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2017
David Quinn
University of Southern Californi
urothelial carcinoma
bladder cancer
KEYNOTE-045 trial
pembrolizumab
docetaxel
vinflunine

Created: 6/5/2017 11:45:25 AM

Dean F. Bajorin, MD, and Peter H. O’Donnell, MD, on Urothelial Cancer: Results From Two KEYNOTE Trials

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2017
Dean Bajorin
Memorial Sloan Kettering
Peter O'Donnell
University of Chicago
urothelial cancer
bladder cancer
KEYNOTE trial
pembrolizumab
paclitaxel
docetaxel
vinflunine

Created: 6/5/2017 11:41:31 AM

Daniel A. Goldstein, MD, on Pembrolizumab for Lung Cancer: Saving Costs by Adjusting Dosage

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2017
Daniel Goldstein
Emory University
Rabin Medical Center
pembrolizumab
lung cancer
cost of care
personal doses
weight-based doses
PD-L1-positive
NSCLC

Created: 6/4/2017 5:45:21 PM

Martin Reck, MD, PhD, on NSCLC: Results of KEYNOTE-024 (German Language Version)

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2016
Martin Reck
LungenClinic
pembrolizumab
platinum-based chemotherapy
first-line therapy
NSCLC
non-small cell lung cancer
lung cancer
advanced lung cancer
PD-L1
tumor proportion score

Created: 10/18/2016 4:14:19 PM

Martin Reck, MD, PhD, on NSCLC: Results of KEYNOTE-024

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2016
Martin Reck
LungenClinic
pembrolizumab
platinum-based chemotherapy
first-line therapy
NSCLC
non-small cell lung cancer
lung cancer
advanced lung cancer
PD-L1
tumor proportion score

Created: 10/10/2016 10:51:34 AM

Arjun V. Balar, MD, on Urothelial Cancer: Results From KEYNOTE-052

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2016
Arjun Balar
NYU Perlmutter Cancer Center
urothelial cancer
bladder cancer
pembrolizumab
KEYNOTE-052
metastatic bladder cancer
advanced bladder cancer
unresectable bladder cancer

Created: 10/10/2016 5:55:51 AM

Omid Hamid, MD, on Melanoma: Results From the KEYNOTE-002 Study

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2016
Omid Hamid
The Angeles Clinic and Research
melanoma
skin cancer
KEYNOTE-002
pembrolizumab
investigator-choice chemotherapy
ipilimumab-refractory

Created: 10/10/2016 5:46:54 AM

Stephen M. Ansell, MD, PhD, on Precision Immunotherapy for Refractory Hodgkin Lymphoma

Type of Page:TapVideo
Edit This Item
Tags for this item:
Pan-Pacific Lymphoma 2016
Stephen Ansell
refractory Hodgkin lymphoma
Mayo Clinic
nivolumab
pembrolizumab

Created: 7/20/2016 10:40:25 AM

Anthony J. Olszanski, RPh, MD, and Caroline Robert, MD, PhD, on Results From the KEYNOTE-001 Melanoma Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
Caroline Robert
Fox Chase
ASCO 2016
Anthony Olszanski
Gustave Roussy
melanoma
pembrolizumab
ipilimumab
KEYNOTE-001

Created: 6/8/2016 11:20:58 AM

Jame Abraham MD FACP on Immunotherapy in Triple-Negative Breast Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
san antonio breast cancer sympos
jame abraham
triple-negative breast cancer
breast cancer
pembrolizumab
immunotherapy
cancer
oncology
asco post

Created: 1/31/2016 9:33:52 AM

Lisa A Carey MD on Pembrolizumab in Triple-Negative Breast Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
san antonio breast cancer sympos
lisa a. carey
pembrolizumab
breast cancer
triple-negative breast cancer
oncology
immunotherapy
asco post

Created: 1/31/2016 9:31:28 AM

John Thompson MD on Advanced Melanoma Treatment Options

Type of Page:TapVideo
Edit This Item
Tags for this item:
NCCN
John Thompson
advanced melanoma
pembrolizumab
trametinib
dabrafenib
nivolumab

Created: 1/31/2016 9:12:37 AM

Jean-Yves Douillard, MD, PhD, on New Perspectives in Small Cell Lung Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
ECC 2015
Jean-Yves Douillard
Centre R Gauducheau
SCLC
tyrosine kinase inhibitor
FGFR
IGFR
drug conjugates
Rova-T
DLL-3
immunotherapy
ipilumumab
nivolumab
pembrolizumab

Created: 1/31/2016 12:42:13 AM

Jean-Charles Soria, MD, PhD, on Results of the KEYNOTE 001 Clinical Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ECC 2015
Jean-Charles Soria
Gustave Roussy
keynote trial
systemic chemotherapy
PDL1 staining
pembrolizumab
liver metastases
NSCLC

Created: 1/31/2016 12:34:44 AM

Toshihiko Doi, MD, PhD, on Esophageal Carcinoma: Study Results From KEYNOTE-028

Type of Page:TapVideo
Edit This Item
Tags for this item:
2016 GI Cancers Symposium
Toshihiko Doi
National Cancer Center Hospital
esophageal carcinoma
KEYNOTE-028
pembrolizumab

Created: 1/30/2016 11:44:13 PM

Dung T. Le, MD, on Noncolorectal GI Cancers: Results From a Phase II Study of Pembrolizumab

Type of Page:TapVideo
Edit This Item
Tags for this item:
2016 GI Cancers Symposium
Dung Le
Johns Hopkins
noncolorectal GI cancers
pembrolizumab

Created: 1/30/2016 11:42:55 PM

Andrew Seidman, MD, and Hope Rugo, MD, on Advanced Breast Cancer: KEYNOTE-028 Study Results

Type of Page:TapVideo
Edit This Item
Tags for this item:
SABCS 2015
Andrew Seidman
Memorial Sloan Kettering
Hope Rugo
UC San Francisco
advanced breast cancer
KEYNOTE-028
pembrolizumab
PD-L1 positive
estrogen-receptor positive
HER2-negative

Created: 12/24/2015 12:47:59 PM

Jame Abraham, MD, on The JAVELIN and KEYNOTE-028 Study Results

Type of Page:TapVideo
Edit This Item
Tags for this item:
SABCS 2015
Jame Abraham
Cleveland Clinic
locally advanced breast cancer
metastatic breast cancer
JAVELIN study
KEYNOTE-028 study
avelumab
anti-PD-L1 antibody
pembrolizumab
PD-L1-positive
estrogen receptor-positive
HER2-negative
breast cancer

Created: 12/24/2015 12:40:28 PM
Order By Item Count
Order Alphabetically